GenomOncology

As a venture capital firm and a healthcare technology company based in Cleveland, Ohio, GenomOncology enables precision medicine by transforming data into actionable information. It offers the GO Precision Medicine Portfolio – a suite of solutions that meet the full range of needs for medical institutions. The portfolio supports technical analysis validation and testing, clinical decision support, collaborative decision support for molecular tumor board workflows, as well as monitoring and discovery analytics – to advance cancer precision medicine.